Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced / Q000276:immunology / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001853:Bone Marrow / Q000276:immunology; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*; D014050:Toluene / Q000506:poisoning
D000961:Antilymphocyte Serum; D014050:Toluene; D003520:Cyclophosphamide